Cyclosporine works by inhibiting T-lymphocyte transcription of IL-2. The long-term use of cyclosporine can be limited by the two major side effects of renal toxicity and hypertension (Grossman ...

Cyclosporine A (CsA) is one of the systemic therapeutic options for moderate-to-severe psoriasis, based on its efficacy and rapidity of action. The current study investigated the response to CsA ...

A few treatments are known to help clear psoriasis symptoms fast, such as Clobex spray, cyclosporine, and Humria. When choosing a psoriasis treatment, however, also consider other factors like side ...

Generalized pustular psoriasis (GPP) is a severe form of psoriasis characterized ... 4-6 Other first-line treatments include infliximab, methotrexate, and cyclosporine. In the case described, GPP was ...

for the treatment of patients 6 years or older with moderate to severe plaque psoriasis who have not responded, or who are intolerant to other systemic therapies, including cyclosporine, methotrexate ...

69 Other molecules, including cyclosporine A, tacrolimus and lifitegrast act by ... use of biological drugs in the treatment of DED and associated conditions such as psoriasis. 109 110 The goal of ...

Psoriasis is a chronic (long-term) inflammatory skin condition that can affect any part of the body, including the scalp. Scalp psoriasis can cause dryness, red patches, bleeding, and dandruff ...

Psoriasis is a chronic (long-term) inflammatory condition that causes red, itchy patches on the skin. It can appear anywhere on the body, but when it affects the genitals, it is referred to as ...

Higher disease acceptance in patients with psoriasis is linked to better outcomes, underscoring the need for psychological resilience in treatment. The study found illness acceptance negatively ...

Please provide your email address to receive an email when new articles are posted on . Researchers reported improvements at 1 month in OSDI scores, corneal fluorescein staining, and conjunctival ...